ERBB2 and invasive breast carcinoma: A study conducted in a cohort containing 4444 invasive breast cancer patients with long-term follow-up showed that mast cell infiltration in invasive breast cancer could be served as an independent good prognostic marker, independent of tumor grade, age, tumor size, ER and Her2 status, and lymph node (47).